The CD99 gene helps immune cells move through blood vessel walls and supports how cells stick together and communicate. If it does not work as expected, immune responses and normal cell growth can become less controlled. Doctors also pay attention to the CD99 gene because unusual activity is linked to some cancers, especially Ewing sarcoma, a cancer that often starts in bone or nearby soft tissue.
What is a gene?
Genes are stretches of DNA that provide your cells with instructions for making molecules or regulating processes in the body. Some genes hold the information needed to make proteins, the working parts of cells. Others mainly help control when certain processes happen, where they happen, and how strongly they occur. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. You can explore this topic further in the LearnHub.
Overview
CD99Gene function
What if the gene works
The CD99 gene helps immune cells stick, move, and pass through blood vessel walls. It also supports normal T cell development and communication between cells.
Risk
What if the gene does not work
Changes in the CD99 gene can reduce or alter the CD99 surface protein, which helps immune cells stick, move, and signal to each other. Milder variants may partly change these processes, while more severe variants can disrupt them more clearly.
Treatment
What does that mean for your treatment
No treatment or drug choice is currently guided by pathogenic variants in the CD99 gene. The CD99 gene is being studied mainly as a tumor marker and possible drug target, especially in Ewing sarcoma, but this has not led to guideline based treatment changes.
Gene function
What if the gene works
Your immune system depends on the CD99 gene for smooth cell to cell contact and movement. Its protein sits on the cell surface, where it helps neighboring cells interact in a controlled way. This is part of how the CD99 gene helps immune cells move through blood vessel walls and reach tissues.
The CD99 gene helps cells recognize and attach to neighboring cells. Its surface protein supports the brief, controlled contacts that immune cells and blood vessel lining cells use during normal cell traffic.
One of the roles of the CD99 gene is to help white blood cells pass between cells lining blood vessels. This allows immune cells to leave the bloodstream and enter tissues as part of normal immune surveillance and routine responses.
In the thymus, the CD99 gene supports normal steps in T cell maturation. This helps developing immune cells interact with nearby cells as they are shaped into a balanced, working immune response.
What is a variant?
A genetic variant is a slight difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, or the way the body reacts to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the CD99 gene can alter the CD99 protein’s shape, stability, or delivery to the cell surface, which may weaken how cells stick, signal, and move. This is how variants influence the CD99 gene's function at the cellular level. Milder variants may only partly reduce protein activity, while more disruptive variants can leave very little working protein or create an unstable protein that cells break down early.
How variants are linked to conditions
The CD99 gene does not yet have a broadly confirmed link to a specific inherited health condition, and current evidence on conditions linked to the CD99 gene is still developing. If you have a reported variant in the CD99 gene, your doctor or genetic counselor can interpret it in the context of your personal and family history.
A variant is not necessarily a diagnosis
Variants in genes are a usual part of human biology, and they are common in the general population. Most do not have a direct effect on health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the CD99 gene itself. If CD99 shows up on a genetic test or in a tumor report, the meaning depends on the exact finding and the larger clinical picture, so it is best discussed with a doctor or genetic counselor.
Inheritance of CD99 variants
For the inheritance of the CD99 gene variants, there is not yet a broadly confirmed Mendelian pattern tied to a specific CD99 related inherited condition. The CD99 gene sits in the pseudoautosomal region of the X and Y chromosomes, so its inheritance does not follow the usual autosomal dominant, autosomal recessive, or typical X linked pattern. You inherit a copy from your parents, and because this region is shared by both sex chromosomes, a father can also pass a CD99 copy to his son.
What does my CD99 result mean for my family?
There is not yet a broadly confirmed inherited pattern tied to a specific health condition for the CD99 gene, and research is still developing. If you have a specific CD99 result and want to understand what it could mean for close relatives, a doctor or genetic counselor can explain it in the context of your family history and the exact result.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the CD99 gene, genetic testing for CD99 gene variants analyzes DNA from blood, saliva, or a cheek swab. A lab reads the gene’s sequence and compares it with the usual reference sequence to identify variants that may then be reported in your results.
When should I consider getting a genetic test?
There is not yet a broadly established, CD99-specific reason for most people to get genetic testing of the CD99 gene. Testing decisions are usually based on your own health history, family history, and whether a doctor or genetic counselor thinks a broader test panel would be more helpful.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, yet how much it explains varies with the condition and the specific type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also influence how the body works. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best interpreted alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic results can also help put a person’s experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. One person may break down a drug more slowly, while another may process it faster or be more sensitive to its effects. These differences are common and can influence how well a treatment works or the chance of side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can shape a person’s response to medications. It focuses on the links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body processes it. This information can support more informed and individualized treatment decisions. If you want to read about this topic in greater detail, you can learn more in the LearnHub.
Drugs influenced by the CD99 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used. Questions about side effects, new symptoms, or how a treatment is working are best discussed with your doctor.
History
CD99 entered medical research through studies of cell surface markers, where it was first recognized as the MIC2 antigen. Initially understood only through visible traits, later recognized as tied to a specific gene, it drew attention because it sits in the pseudoautosomal region shared by the X and Y chromosomes. In the 1980s and 1990s, CD99 became especially important in pathology because strong CD99 staining helped doctors identify Ewing sarcoma and related tumors under the microscope. That role made the CD99 gene a familiar name in cancer diagnostics long before many patients ever heard about genes directly. With each decade, genetic studies refined the picture, linking earlier laboratory findings to the gene itself and clarifying its place in human genetics.